4.01
Schlusskurs vom Vortag:
$3.91
Offen:
$3.91
24-Stunden-Volumen:
4.58M
Relative Volume:
1.29
Marktkapitalisierung:
$447.52M
Einnahmen:
$2.35B
Nettoeinkommen (Verlust:
$-74.42M
KGV:
-4.266
EPS:
-0.94
Netto-Cashflow:
$150.93M
1W Leistung:
-4.52%
1M Leistung:
-38.21%
6M Leistung:
-50.55%
1J Leistung:
-65.16%
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Vergleichen Sie EVH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
EVH
Evolent Health Inc
|
4.01 | 436.36M | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
242.28 | 39.67B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
76.31 | 13.33B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
51.31 | 9.70B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.43 | 8.50B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.25 | 6.74B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-13 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Will Evolent Health Inc Class stock justify high valuationProduct Launch & Reliable Price Action Trade Plans - Newser
What market sentiment indicators show for Evolent Health Inc Class stockEarnings Risk Report & Daily Oversold Stock Bounce Ideas - Newser
Can Evolent Health Inc. stock weather global recessionEarnings Risk Summary & Reliable Trade Execution Plans - Newser
How Evolent Health Inc. (9EH) stock expands through international marketsJuly 2025 Setups & Entry Point Confirmation Signals - Newser
Will Evolent Health Inc Class stock outperform foreign stocksEntry Point & Low Risk Entry Point Tips - Newser
How geopolitical risks impact Evolent Health Inc Class stockPortfolio Gains Report & Verified Stock Trade Ideas - Newser
Piper Sandler slashes Evolent Health stock price target to $6 from $18 - Investing.com Canada
Evolent Health Appoints Jill Smith to Board - TipRanks
Evolent Health (EVH) names new independent director and reiterates Q4 2025 guidance - Stock Titan
Is Evolent Health Inc. (9EH) stock a buy for dividend portfoliosJuly 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Is Evolent Health Inc. stock a buy before product launchesMarket Activity Summary & Consistent Profit Focused Trading Strategies - Newser
Geode Capital Management LLC Has $30.04 Million Stock Position in Evolent Health, Inc $EVH - MarketBeat
Investment Report: What hedge fund activity signals for Evolent Health Inc. stockJuly 2025 Market Mood & Reliable Breakout Stock Forecasts - BỘ NỘI VỤ
Responsive Playbooks and the EVH Inflection - news.stocktradersdaily.com
How the Narrative for Evolent Health Is Shifting After Analyst Revisions and New Developments - Yahoo Finance
Hopeful Week For Insiders Who Bought US$1.38m Of Evolent Health Stock - simplywall.st
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know - The Globe and Mail
Evolent Health Secures Upgrades Amid AI Growth Push - StocksToTrade
Evolent Health’s Stock Surges Amidst Strategic Upgrades and Market Optimism - StocksToTrade
Evolent Health Gains Momentum as Analysts Upgrade Ratings - timothysykes.com
Evolent Health Gains Momentum with Strategic AI Initiatives - timothysykes.com
Evolent Health Stock Gains Momentum Amid Strategic Moves - StocksToTrade
Citigroup Has Lowered Expectations for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Evolent Health Sees Uptrend with Analyst Upgrades and AI Initiatives - StocksToTrade
Evolent Health, American Oncology Network Partner to Streamline Cancer Care - MSN
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know - Yahoo Finance
Evolent Health (EVH): Citigroup Adjusts Price Target While Maint - GuruFocus
Can Evolent Health Inc. (9EH) stock ride next bull market cycleJuly 2025 Volume & Technical Entry and Exit Tips - newser.com
Evolent Health Inc (9EH.SG) Insider Ownership & Holdings - Yahoo! Finance Canada
Evolent Health (EVH) Price Target Decreased by 28.65% to 11.40 - MSN
Evolent Health (NYSE:EVH) Director Acquires $38,200.00 in Stock - MarketBeat
TD Cowen reaffirms Buy rating on Evolent Health stock amid selloff - Investing.com Canada
Stocks making big moves yesterday: Cogent, Wix, WESCO, LGI Homes, and Evolent Health - The Globe and Mail
Evolent Health: Overly Pessimistic Valuation Presents a Buy Opportunity Amidst Exaggerated Concerns - TipRanks
Can Evolent Health Inc. (9EH) stock hold up in economic slowdown2025 AllTime Highs & Daily Volume Surge Signals - newser.com
Engaged Capital takes new position in BlackLine, Cognex, lowers stake in Evolent Health in Q3 moves - MSN
Can Evolent Health Inc. (9EH) stock sustain revenue momentumPortfolio Performance Report & AI Based Trade Execution Alerts - newser.com
Applying Wyckoff theory to Evolent Health Inc. stockTrade Risk Assessment & Daily Chart Pattern Signals - newser.com
Is Evolent Health Inc. stock oversold or undervaluedJuly 2025 Selloffs & Free High Return Stock Watch Alerts - newser.com
Is Evolent Health Inc. stock positioned well for digital economyEarnings Risk Summary & Advanced Technical Analysis Signals - newser.com
Why Evolent Health Inc. stock is popular among millennials - newser.com
Insider Buying: Brendan Springstubb Acquires Shares of Evolent H - GuruFocus
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):